These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8807671)

  • 1. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of morphine tolerance and abstinence on cellular immune function.
    Bhargava HN; Thomas PT; Thorat S; House RV
    Brain Res; 1994 Apr; 642(1-2):1-10. PubMed ID: 8032870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of naltrexone on morphine-induced tolerance and physical dependence and changes in cellular immune function in mice.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Brain Res; 1995 Aug; 690(1):121-6. PubMed ID: 7496798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-tolerance to the hypothermic effect of delta 8-tetrahydrocannabinol 11-hydroxy-delta 8-tetrahydrocannabinol and chlorpromazine in the mouse.
    Yamamoto I; Watanabe K; Narimatsu S; Hamajima K; Yoshimura H
    Eur J Pharmacol; 1985 May; 111(2):159-66. PubMed ID: 2990949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
    Smith PB; Welch SP; Martin BR
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1381-7. PubMed ID: 8138952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical exposure to 2-butoxyethanol alters immune responses in female BALB/c mice.
    Singh P; Zhao S; Blaylock BL
    Int J Toxicol; 2001; 20(6):383-90. PubMed ID: 11797820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated administration of phytocannabinoid Δ(9)-THC or synthetic cannabinoids JWH-018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner.
    Tai S; Hyatt WS; Gu C; Franks LN; Vasiljevik T; Brents LK; Prather PL; Fantegrossi WE
    Pharmacol Res; 2015 Dec; 102():22-32. PubMed ID: 26361728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune function alterations in mice tolerant to delta9-tetrahydrocannabinol: functional and biochemical parameters.
    Massi P; Sacerdote P; Ponti W; Fuzio D; Manfredi B; Viganó D; Rubino T; Bardotti M; Parolaro D
    J Neuroimmunol; 1998 Dec; 92(1-2):60-6. PubMed ID: 9916880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice.
    Castañé A; Robledo P; Matifas A; Kieffer BL; Maldonado R
    Eur J Neurosci; 2003 Jan; 17(1):155-9. PubMed ID: 12534979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
    Watanabe K; Yamamoto I; Yoshimura H
    Eur J Pharmacol; 1983 Oct; 94(3-4):349-51. PubMed ID: 6317407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
    Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
    Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential suppression of T-cell subpopulations by thc (delta-9-tetrahydrocannabinol).
    Pross SH; Klein TW; Newton CA; Smith J; Widen R; Friedman H
    Int J Immunopharmacol; 1990; 12(5):539-44. PubMed ID: 2170281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes.
    Trisler K; Specter S
    Int J Immunopharmacol; 1994 Jul; 16(7):593-603. PubMed ID: 7523319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats.
    Vela G; Fuentes JA; Bonnin A; Fernández-Ruiz J; Ruiz-Gayo M
    Brain Res; 1995 May; 680(1-2):142-7. PubMed ID: 7663970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of brain histamine in delta 9-tetrahydrocannabinol tolerance and withdrawal.
    Verberne AJ; Fennessy MR; Lewis SJ; Taylor DA
    Pharmacol Biochem Behav; 1985 Aug; 23(2):153-9. PubMed ID: 2997805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana and immunity: tetrahydrocannabinol mediated inhibition of lymphocyte blastogenesis.
    Specter S; Lancz G; Hazelden J
    Int J Immunopharmacol; 1990; 12(3):261-7. PubMed ID: 2158486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.